Clinical and Applied Thrombosis/Hemostasis · 2015 · 17 citations · 24 references
MedicineHematologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyHemostasisDeep Vein ThrombosisPulmonary EmbolismThrombosisVenous ThromboembolismVitamin DVitamin SupplementationControl Group DesignMatched Control GroupNutritional Vitamin D StatusSerum 25-Hydroxyvitamin D StatusTherapeutic Vitamin D SupplementationThrombotic Risk AssessmentThrombotic Risk ReductionVitamin D Biomarkers
High plasma level of P-selectin is associated with the development of venous thromboembolism (VTE). Furthermore, supplementation of vitamin D could decrease thrombotic events. Hence, this study was designed to examine whether the administration of vitamin D can influence the plasma level of P-selectin in patients with VTE. In the randomized controlled trial, 60 patients with confirmed acute deep vein thrombosis and/or pulmonary embolism (PE) were randomized into the intervention (n = 20) and control (n = 40) groups. The intervention arm was given an intramuscular single dose of 300 000 IU vitamin D3 Plasma level of 25-hydroxy vitamin D, P-selectin, and high-sensitive C-reactive protein (hs-CRP) was measured at baseline and 4 weeks after. The plasma level of P-selectin (95% confidence interval = -5.99 to -1.63, P = .022) and hs-CRP (P = .024) significantly declined in vitamin D-treated group, while only hs-CRP was significantly decreased in the control group (P = .011). However, the magnitude of these reductions was not statistically significant. This study could not support the potential benefit of the high-dose vitamin D on plasma level of P-selectin and hs-CRP in patients with VTE.
24
Stefanie Schulze Schleithoff, Armin Zittermann, Gero Tenderich et al. · American Journal of Clinical Nutrition · 2006 · 927 citations
Mai Ohsawa, Takatoshi Koyama, Keiko Yamamoto et al. · Circulation · 2000 · 145 citations · Full text
Medicine, Pharmacology, Hemostasis +11